• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pulse Biosciences CS (NQ: PLSE )

    17.19 -0.29 (-1.66%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 70,366
    Open 17.50
    Bid (Size) 16.55 (1)
    Ask (Size) 17.50 (1)
    Prev. Close 17.48
    Today's Range 16.61 - 17.68
    52wk Range 3.780 - 22.69
    Shares Outstanding 54,902,942
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024
    Pulse Biosciences just reported results for the second quarter of 2024. 
    Via InvestorPlace
    Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga

    Performance

    YTD
    +55.99%
    +55.99%
    1 Month
    +13.84%
    +13.84%
    3 Month
    +40.33%
    +40.33%
    6 Month
    +60.96%
    +60.96%
    1 Year
    +266.52%
    +266.52%

    More News

    Read More
    Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
    From Pulse Biosciences, Inc.
    Via Business Wire
    PLSE Stock Earnings: Pulse Biosciences Reported Results for Q1 2024
    Via InvestorPlace
    Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
    From Pulse Biosciences, Inc.
    Via Business Wire
    Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    S&P 500, Nasdaq Extend Record Highs; Dow Up Triple Digits
    Via Talk Markets
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
    From Pulse Biosciences, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
    From Pulse Biosciences, Inc.
    Via Business Wire
    Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Pulse Biosciences Enhances Executive Leadership Team
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
    From Pulse Biosciences, Inc.
    Via Business Wire
    Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
    From Pulse Biosciences, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.